Table of Contents
Introduction
The skincare company Rodan + Fields was started in 2002 by dermatologists Dr. Katie Rodan and Dr. Kathy Fields. Multi-level marketing (MLM), which is how the company does business, and Proactiv, which is its main product, have helped it become well-known. In the past few years, Rodan + Fields has had to deal with several legal issues that have to do with how it sells its many products. In the next few paragraphs, we’ll talk about how the class-action lawsuit against Rodan + Fields’ Lash Boost product turned out.
What is Lash Boost and how it works?
A product called Lash Boost, which is a lash serum can make eyelashes look better. The product came out in 2016, and it was advertised as a safe and effective way to grow longer, fuller, and thicker eyelashes. The first time it was done was in 2016. Rodan + Fields advertised and sold their product, Lash Boost, using a business model called multi-level marketing (MLM). Under this plan, independent consultants were given incentives to tell their networks about the product and sell it.
The suit in the Name of the People
In 2019, a class-action lawsuit was filed against Rodan + Fields in the U.S. District Court for the Central District of California. Isopropyl cloprostenol is a prostaglandin analog that is made in a lab. It is thought to be one of the ingredients in Lash Boost. Glaucoma is also treated with these kinds of drugs. The complaint says that this ingredient is in Lash Boost.
According to the complaint, Rodan + Fields advertised Lash Boost as a beauty product. However, since it contained isopropyl cloprostenol, it was a medicine and had to be regulated by the Food and Drug Administration (FDA) (FDA). The lawsuit said that Rodan + Fields didn’t follow FDA rules for selling and marketing drugs and that the company didn’t tell people about the risks of using a product with a prostaglandin analog. Both of these claims were made because it was said that the company didn’t have enough warning labels.
Settlement
In March 2021, Rodan + Fields announced that it had reached a settlement agreement in the class-action lawsuit about Lash Boost. As part of the settlement agreement to end the lawsuits against the company, Rodan + Fields has agreed to pay $9.5 million.
In addition to the money, Rodan + Fields has also agreed to change how it markets Lash Boost in the future. The company’s marketing materials will no longer have before-and-after pictures, and they will have warnings about the risks of using a product with a prostaglandin analog. Customers who bought Lash Boost between January 1, 2016, and September 30, 2020, and Rodan + Fields has agreed to refund them, can do so.
The Consequences of the Agreement on Settlement
The end of the Lash Boost class-action lawsuit has several effects on the business model of multi-level marketing (MLM) and the skincare market.
Importance of following rules made by the FDA
First, the settlement stresses how important it is to follow the rules set by the FDA for advertising and distributing pharmaceutical products. The FDA has rules about products that have certain ingredients, like prostaglandin analogs. If you don’t follow these rules, you could get in trouble with the law and have to pay fines. The Food and Drug Administration (FDA) has rules about products that have certain ingredients, like prostaglandin analogs.
Multi-level marketing business structures are inherently risky
Second, the settlement shows how multi-level marketing business structures are inherently risky. Multi-level marketing (MLM) companies often use independent consultants to promote and sell their products. However, this can lead to marketing messages and promises that don’t match up. MLM companies must make sure that their marketing materials are accurate and truthful, and that their sales consultants have the right training to follow FDA rules.
Legal problems related to product promotion could cause financial damage
Lastly, the settlement shows how legal problems related to product promotion could cause financial damage. The $9.5 million settlement is a big loss for Rodan + Fields, and it shows how important it is for businesses to be proactive in their efforts to follow the law and to act quickly when legal problems arise.
Conclusion
Rodan + Fields has agreed to pay $9.5 million to settle a class-action lawsuit that was started by their Lash Boost product. As part of the settlement, the company also agreed to change how it markets the product. The settlement shows how important it is to follow the rules that the FDA sets out.
You Might also like
Analysis of a Financial Education Services: $715 brokerage on a $499 Sale?
Financial Education Services pyramid scheme leads to a $1 million fine by the FTC
